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Abstract
Introduction The helmet may be an effective interface for the
delivery of noninvasive positive pressure ventilation. The high
internal gas volume of the helmet can act as a 'mixing chamber',
in which the humidity of the patient's expired alveolar gases
increases the humidity of the dry medical gases, thus avoiding
the need for active humidification. We evaluated the
temperature and humidity of respiratory gases inside the helmet,
with and without a heated humidifier, during continuous positive
airway pressure (CPAP) delivered with a helmet.
Methods Nine patients with acute respiratory failure (arterial
oxygen tension/fractional inspired oxygen ratio 209 ± 52
mmHg) and 10 healthy individuals were subjected to CPAP. The
CPAP was delivered either through a mechanical ventilator or by
continuous low (40 l/min) or high flow (80 l/min). Humidity was
measured inside the helmet using a capacitive hygrometer. The
level of patient comfort was evaluated using a continuous scale.
Results In patients with acute respiratory failure, the heated
humidifier significantly increased the absolute humidity from
18.4 ± 5.5 mgH2O/l to 34.1 ± 2.8 mgH2O/l during ventilator
CPAP, from 11.4 ± 4.8 mgH2O/l to 33.9 ± 1.9 mgH2O/l during
continuous low-flow CPAP, and from 6.4 ± 1.8 mgH2O/l to 24.2
± 5.4 mgH2O/l during continuous high-flow CPAP. Without the
heated humidifier, the absolute humidity was significantly higher
with ventilator CPAP than with continuous low-flow and high-
flow CPAP. The level of comfort was similar for all the three
modes of ventilation and with or without the heated humidifier.
The findings in healthy individuals were similar to those in the
patients with acute respiratory failure.
Conclusion The fresh gas flowing through the helmet with
continuous flow CPAP systems limited the possibility to
increase the humidity. We suggest that a heated humidifier
should be employed with continuous flow CPAP systems.
Introduction
During normal spontaneous breathing, ambient air – apart
from being filtered for particles and micro-organisms by the
nose and upper airways – is heated to body temperature and
humidified, so that it is saturated by the time it reaches the
alveoli [1]. Consequently, when the upper airways are
bypassed (as in a patient with an endotracheal tube) medical
gases, which are drier than ambient air [2], must be heated
and humidified by heated humidifiers or heat-moisture
exchangers [1] in order to avoid bronchial inflammation, cell
damage, impairment of mucociliary clearance and loss of pul-
monary function [3-6].
During noninvasive positive pressure ventilation (NPPV;
defined as any form of ventilation support applied without an
endotracheal tube [7]) the upper airways are not bypassed,
and so theoretically they should adequately heat and humidify
medical gases. However, out of a group of patients with
severe obstructive sleep apnoea syndrome who were treated
with nasal continuous positive airway pressure (CPAP) and
administered nonhumidified ambient air, up to 60% suffered
from nasal congestion, stuffiness and dryness [8,9]. These air-
way symptoms were mainly caused by the considerable one-
way flow of ambient air through the nose and out of the mouth
during mouth leaks, causing the release of several vasoactive
amines and leukotrienes [10,11]. The use of a heated
CPAP = continuous positive airway pressure; NPPV = noninvasive positive pressure ventilation.Critical Care    Vol 12 No 2    Chiumello et al.
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humidifier reduced nasal congestion [10,12], upper airway
dryness, and dry mouth or nose [13]. In addition, the use of a
heated humidifier increased patient satisfaction and the
number of hours with CPAP application per night, and the
patients indicated that they felt more refreshed on awakening
[14].
In clinical practice, the use of a heated humidifier during CPAP
is regarded to be optional, and it is normally utilized only when
the patient exhibits symptoms of nasal or oral dryness or dur-
ing prolonged utilization [15-19]. A recent review of NPPV
[20] concluded that humidification is usually unnecessary dur-
ing short-term application of CPAP. However, the last interna-
tional consensus conference on NPPV in intensive care [7]
stated that inadequate humidification of medical gases may
cause patient distress, especially if the gases are supplied via
a pipeline or cylinder.
At the present time there is no information on the optimal level
of humidity of inspired gases during the NPPV. The American
National Standards Institute suggested, although not directly
for NPPV, that 10 mgH2O/l of absolute humidity is the lowest
acceptable level needed to minimize mucosal damage in the
upper airways [21].
In the acute setting, NPPV is usually delivered via a face mask,
but this may cause discomfort, skin lesions and gas leaks [7].
To enhance patient comfort and to permit longer periods of
NPPV, a new device – the 'helmet' – has been introduced [22-
24]. Similar to the carbon dioxide rebreathing that occurs with
use of the helmet [25], the high internal gas volume could also
serve as a 'mixing chamber' between the heated and humidi-
fied expired gases and the dry medical gases entering the hel-
met. This could raise the levels of heat and humidity of the
medical gases, thus avoiding the need for a heated humidifier.
The final humidity inside the helmet will depend mainly on two
factors: the amount of humidity in the patient's expired gases
and the flow of fresh medical gases into the helmet. In addition,
the humidifying capability of the respiratory tract may also be
influenced by the presence of airway or pulmonary disease
[26-28].
The aim of this study, conducted in patients with acute respi-
ratory failure and in a group of healthy individuals, was to eval-
uate the temperature and humidity of respiratory gases within
the helmet, with and without a heated humidifier, during CPAP
delivered with a continuous high-flow and low-flow system or
with a modern mechanical ventilator.
Materials and methods
Population
Two groups of individuals were studied. The first group
included nine patients with acute respiratory failure who
required CPAP. The patients' characteristics are shown in
Table 1. To be eligible for inclusion in the study, the patients
were required to be clinically and haemodynamically stable.
The second group included 10 healthy nonsmokers (four
males, mean age 25.5 ± 2.8 years and weight 74.8 ± 16.1 kg)
with no airway disease, rhinitis, nasal surgery, or upper airway
infections during the preceding month.
Each patient was informed about the procedure and a physi-
cian not involved in the study protocol was present to provide
patient care. The study was approved by the institutional
review board of our hospital and informed consent was
obtained in accordance with Italian national regulations.
Interface
The helmet (Castar, Starmed, Modena, Italy) is a transparent,
latex-free, polyvinylchloride hood, which is joined by a metal
ring to a soft polyvinylchloride collar. Two underarm straps
attached to the ring prevent it from moving upward when the
gas pressurizes it.
The helmet has an internal gas volume of 15 l, which is
reduced to approximately 12 l when the head is inserted into
the helmet [24]. A physician excluded the possibility of air leak-
age by passing a hand around the collar of the helmet.
Protocol
The individuals were studied in the semirecumbent position. In
the patients, the inspired oxygen fraction and the level of
CPAP were maintained constant at the levels previously
selected by the attending physician, whereas in healthy indi-
viduals the inspired oxygen fraction and the level of CPAP
were kept constant at 21% and 5 cmH2O, respectively.
Different modes of ventilation were evaluated. The first mode
was ventilator CPAP, delivered by a SERVO 300C ventilator
(Maquet, Solna, Sweden) set to CPAP with the flow trigger
regulated at medium sensitivity. The bias flow rate for the flow
trigger was set at 2 l/minute. The second mode was continu-
ous low-flow CPAP (40 l/minute; CPAP flow generator;
Harold, Milan, Italy) delivered by a valveless system equipped
with a latex reservoir bag with a volume of 10 l at atmospheric
pressure and 20 l at 20 cmH2O pressure (Harold) [29]. The
third mode was continuous high-flow CPAP (80 l/minute),
delivered by the same valveless system as above [29]. A
spring-loaded mechanical positive end-expiratory pressure
valve (Medivalv, Vital Signs, Totowa, N.Y., USA) was used.
A Fisher & Paykel MR 730 heated humidifier (Fisher & Paykel,
Auckland, New Zeland) equipped with a standard plastic dis-
posable circuit was used as a conditioning system. The medi-
cal gas was conditioned by flowing it through a plastic
chamber (the humidifying chamber) across the surface of
warmed sterile water (vaporization surface). The temperature
of the inspiratory gas was monitored by a probe at the end of
the inspiratory line and at the chamber outlet. Theoretically,
with the MR 730 the water reservoir was heated until theAvailable online http://ccforum.com/content/12/2/R55
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inspiratory gas at the end of the inspiratory line reached the
preset temperature [30]. The temperature level of the heated
humidifier was set at 37°C.
Each mode of ventilation was evaluated, in random order, with
and without the heated humidifier. A total of six conditions
were tested.
Measurements
Room temperature was constant at 20 to 22°C. To stabilize
the system in each condition, individuals were ventilated for at
least 20 minutes before any measurements were taken.
A capacitive hygrometer (Hygroclip, Rotronic, Switzerland)
was used to measure temperature and relative humidity inside
the helmet (range for relative humidity 5% to 99%). The sys-
tem incorporates a layer of plastic polymer between two elec-
trodes, which – depending on humidity – can absorb
molecules of water. Changes in capacity are correlated to the
relative humidity. This system has a very low dead time and
good accuracy, with an error of 0°C and no variations with
time. At the end of each measurement the tip of the capacitive
hygrometer was dried to avoid any possible measurement
error.
The temperature and relative humidity inside the helmet were
previously found to be similar in the different positions within
the helmet.
All signals were amplified, digitized and recorded at 0.5 Hz
using a data acquisition software (Colligo, Elekton, Milan,
Italy). In each condition, on average, three or four readings
from the probe were computed. The absolute humidity was
computed using the following equation: absolute humidity =
relative humidity × (0.0387 × T^2 - 0.6066 × T + 13.776),
where T is the temperature (in °C). The respiratory rate and
tidal volume were obtained using the ventilator sensor. The
absence of any autotriggering phenomena was ensured.
Subjective evaluation
At the end of each study condition, patient comfort was rated
using a continuous scale. Participants were asked to score
their response to the question 'How do you feel in the present
condition?' by placing a mark on a continuous line (length 10
cm), ranging from 'worst' (0 cm), 'poor' (2.5 cm), 'sufficient' (5
cm), 'good' (7.5 cm), to 'best feeling' (10 cm) [24]. The partic-
ipants were carefully instructed on how to use the scale before
starting the protocol.
Statistical analysis
Ten patients were estimated to be necessary to demonstrate
a difference of approximately 3 mgH2O/l in absolute humidity
at a statistical significance of 0.05 (two tailed) and a power of
0.80 with a two-way analysis of variance design. Results are
expressed as mean ± standard deviation. A P value less than
0.05 was considered significant. We compared the three
CPAP systems with and without the heated humidifier using
Table 1
Patients' characteristics
Patient Age (years) Sex Weight 
(kg)
CPAP 
(cmH2O)
PaO2/FiO2 
(mmHg)
PaCO2 
(mmHg)
pH RR 
(breaths/
minute)
Cause of 
ARF
1 51 Female 110 7.5 290 70 7.25 25 Acute 
exacerbation 
of COPD
2 78 Male 90 7.5 274 63 7.28 22 Acute 
exacerbation 
of COPD
3 63 Male 80 5 230 65 7.27 30 Acute 
exacerbation 
of COPD
4 77 Female 70 5 170 29 7.44 25 CHF
5 64 Male 95 5 216 37 7.38 25 Pneumonia
6 74 Female 75 5 170 38 7.45 24 Pneumonia
7 47 Male 90 10 155 34 7.51 25 Pneumonia
8 79 Female 70 10 142 39 7.45 20 CHF
9 72 Female 70 10 225 41 7.47 25 CHF
Mean ± SD 67.2 ± 11.8 4 males/5 
females
83.3 ± 13.9 7.2 ± 2.3 209 ± 52 46.2 ± 15.3 7.39 ± 0.1 24.5 ± 2.7
ARF, acute respiratory failure; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway 
pressure; FiO2, inspired oxygen fraction; PaO2, partial arterial pressure of oxygen; RR, respiratory rate; SD, standard deviation.Critical Care    Vol 12 No 2    Chiumello et al.
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two-way analysis of variance for repeated measures, followed
– when appropriate – by the Holm-Sidak test.
Comparisons within the same CPAP system in patients with
acute respiratory failure and in healthy individuals were con-
ducted using a t-test. The statistical analysis was performed
using Sigma Stat Software (SPSS, Chicago, IL, USA).
Results
The temperature and humidity of ambient air, pipeline medical
gases and medical gases leaving the mechanical ventilator are
shown in Table 2.
Patients with acute respiratory failure
During ventilator CPAP the mean tidal volume and respiratory
rate were 0.67 ± 0.12 l and 18.0 ± 4.4 breaths/minute,
respectively. Application of the heated humidifier during all
CPAP modes tested significantly raised the temperature, and
absolute and relative humidity compared with CPAP without
the heated humidifier (Table 3). Temperature and absolute and
relative humidity were significantly higher with ventilator CPAP
with and without the heated humidifier compared with contin-
uous high-flow CPAP and continuous low-flow CPAP (with
the exception of temperature for low-flow CPAP; Table 3).
Continuous low-flow CPAP exhibited a significantly higher
temperature, absolute and relative humidity compared with
continuous high-flow CPAP.
There was no difference in the ability to heat and humidify
medical gases between the patients with acute respiratory fail-
ure and the healthy individuals. Level of comfort was quite
good and without difference between the use or non-use of
heated humidifier and the CPAP modes (Figure 1a).
Healthy individuals
During ventilator CPAP, the mean tidal volume and respiratory
rate were 1.02 ± 0.19 l and 12.2 ± 3.4 breaths/minute,
respectively. The findings in healthy subjects and in patients
with acute respiratory failure were similar except for the contin-
uous low-flow and high-flow CPAP, which exhibited similar
temperature and humidity (Table 4). Comfort level was similar
with and without the heated humidifier and in all three CPAP
modes (Figure 1b).
Discussion
The main findings of this study, which evaluated the condition-
ing of medical gases during CPAP with helmet, were as fol-
lows. First, the use of a heated humidifier during ventilator
CPAP, continuous low-flow and high-flow CPAP significantly
increased the temperature and humidity of the gasses within
the helmet. Second, taking 10 mgH2O/l as the absolute mini-
mum humidity required for medical gases during NPPV, this
level was achieved without use of the heated humidifier only
during ventilator CPAP. Third, patients with acute respiratory
failure and healthy individuals exhibited similar abilities to heat
and humidify medical gases. Finally, use of the heated humidi-
fier did not affect the level of patients' comfort.
The airway mucosa (nose, sinuses, trachea and bronchi) is
highly vascular, rich in mucosal glands and covered by a
Table 2
Temperature and humidity of ambient air and of the medical gas under various conditions
Temperature (°C) Absolute humidity (mgH2O/l) Relative humidity (%)
Ambient air 20–22 9–12 50–60
Pipeline medical gases 20–21 3–4 18–25
Ventilator medical gases 22–26 3–4 16–19
Table 3
Temperature and humidity of the medical gas with and without the heated humidifier in patients with acute respiratory failure
Temperature (°C) Absolute humidity (mgH2O/l) Relative humidity (%)
CPAPVENT with HH 32.4 ± 1.4a,c 34.1 ± 2.8a,b,c 98.1 ± 1.8a,c
CPAPVENT without HH 29.5 ± 2.0a 18.4 ± 5.5a,b 61.4 ± 14.7a,b
CPAPLF with HH 32.3 ± 1.0a,c 33.9 ± 1.9a,c 98.0 ± 1.0a,c
CPAPLF without HH 28.5 ± 1.7a 11.4 ± 4.8a 40.4 ± 15.5c
CPAPHF with HH 29.4 ± 1.1c 24.2 ± 5.4c 82.3 ± 18.3c
CPAPHF without HH 27.4 ± 1.2 6.4 ± 1.8 24.6 ± 6.9
aP < 0.05 versus CPAPHF; bP < 0.05 versus CPAPLF; cP < 0.05 versus each mode of CPAP without HH. CPAP, continuous positive airway 
pressure; CPAPVENT, ventilator CPAP; CPAPLF, continuous low-flow CPAP; CPAPHF, continuous high-flow CPAP; HH, heated humidifier.Available online http://ccforum.com/content/12/2/R55
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hygroscopic mucus [1]. During spontaneous breathing, the
ambient air, which under normal indoor conditions, has a tem-
perature of 20°C to 24°C and an absolute humidity between
9 and 12 mgH2O/l, is progressively heated and humidified
through the respiratory system by evaporation of water from
the airway mucosa [31]. The air is heated and humidified until
it becomes fully saturated by the time it reaches the alveoli (i.e.,
it reaches an absolute humidity of 44 mgH2O/l at a tempera-
ture of 37°C). During expiration, the temperature and humidity
of the alveolar gas gradually drop, reaching a temperature of
32°C to 34°C and an absolute humidity of 27 to 34 mgH2O/l
at the nose [1,32]. Thus, at least under normal ambient condi-
tions, the temperature and humidity of the expired gases are
always higher than those of ambient air [32,33].
Conversely, in patients with severe obstructive sleep apnoea
receiving nasal CPAP delivering ambient air at high flow, the
humidity of the inspired gas fell significantly [16]. This high
flow of ambient air through the nose increased nasal resist-
ance [12,13], causing discomfort as a result of dryness of the
nose and mouth [10]. However, a heated humidifier, by
increasing the humidity of the air, relieves or prevents these
symptoms [13,14,16].
Medical gases, which are a mixture of oxygen with air, supplied
through a pipeline or from a cylinder, are drier than ambient air
(Table 2). When these gases are not adequately humidified
they can deplete the moisture of the mucosa, reducing ciliary
activity and causing functional alterations in the upper airway
epithelium [1,3]. It appears reasonable from a physiological
point of view that the medical gases should more closely
mimic the conditions of normal ambient air [34].
In patients with acute respiratory failure, the face mask is more
often used to deliver CPAP rather than a nasal mask because
it can deliver higher ventilation pressures [7]. The face mask,
with its higher anatomical dead space than that of the nasal
mask, can maintain the humidity returned during the expiratory
phase, thus increasing the humidity of the inspired gases and
counterbalancing the difference between the dry inspired
gases and the expired gases at each cycle. Araujo and cow-
orkers [16] found similar levels of humidity using a face mask
without a humidifier and a nasal mask with a humidifier. The
helmet, which may be a valid alternative interface to the face
mask during CPAP [22,24], has a high internal gas volume,
similar to a semiclosed environment [25] in which the expired
heat and humidity can mix with the fresh gas, thus raising the
temperature and humidity of the dry medical gases.
The indications for NPPV depend on the goals of therapy, for
instance to reduce the carbon dioxide or to improve oxygena-
tion in patients with acute respiratory failure, and may differ
depending upon the clinical context [7]. However, the
absence of large-scale controlled studies obtained in different
types of populations mean that NPPV cannot unequivocally be
indicated in all patients with acute respiratory failure [7,20].
In the present study, we found higher humidity with ventilator
CPAP than with the continuous flow CPAP system, and it was
also higher than the lowest level required [21,34]. This sug-
gests that the helmet acts as a 'humidity mixing chamber'
between expired gases and dry medical gases, making it
unnecessary to use a heated humidifier.
Continuous gas flow, as compared with the intermittent flow
that occurs during ventilator CPAP, dilutes expired humidity to
a greater extent, and therefore it is more difficult to humidify the
medical gases adequately. In these conditions a heated
humidifier is necessary. Any leakage from the helmet during
ventilator CPAP could increase the gas flow delivered by the
Figure 1
Comfort in patients with acute respiratory failure and healthy individuals  with and without heated humidifier Comfort in patients with acute respiratory failure and healthy individuals 
with and without heated humidifier. Shown are average ratings of com-
fort in (a) patients with acute respiratory failure and in (b) healthy indi-
viduals with the heated humidifier (white bar) and without the heated 
humidifier (black bar). CPAP, continuous positive airway pressure; 
CPAPHF, continuous high-flow CPAP; CPAPLF, continuous low-flow 
CPAP; CPAPVENT, ventilator CPAP.Critical Care    Vol 12 No 2    Chiumello et al.
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ventilator to maintain the positive end-expiratory pressure level
constant, causing an increase in the proportion of the dry fresh
gas mixing with the expired gases, thus reducing the ability to
achieve adequate humidification.
The heated humidifier significantly increased the temperature
and humidity of the medical gases, both by heating and humid-
ifying the medical gases passing through the humidifying
chamber, and by achieving a higher level of humidity in the
expired gases as they mix with the gases inside the helmet
[35]. The heated humidifier with the ventilator CPAP and the
continuous low-flow CPAP caused a temperature and abso-
lute humidity similar to those commonly employed during inva-
sive mechanical ventilation [36]. However, with the continuous
flow CPAP system, as opposed to the intermittent flow of ven-
tilator CPAP, the heated humidifier did not deliver enough
energy to heat the water in the humidification chamber prop-
erly, so the medical gases were less conditioned [30].
We studied a rather heterogeneous population of patients
with acute respiratory failure, at a range of CPAP from 5 to 10
cmH2O. The main determinant of the temperature and humid-
ity reached inside the helmet was the inspiratory gas flow
passing through the helmet and not the level of CPAP.
In the present study the high temperature and absolute humid-
ity reached using the heated humidifier with ventilator CPAP
and continuous low-flow CPAP reduced the transparency of
the helmet wall. However, patients rated their comfort similarly,
independent of the level of humidity, at least for the short
period of investigation reported here.
Previous studies have speculated that airway or pulmonary
disease could interfere with the humidifying function of the res-
piratory tract [26-28]. We did not identify any difference
between patients with acute respiratory failure and healthy
individuals in terms of the temperature and humidity reached
by the medical gases. This suggest (although it was not meas-
ured) that the humidity of the expired gases mixed with the
fresh gases was similar in patients with acute respiratory fail-
ure and healthy individuals. Primiano and colleagues [33]
found no difference in the temperature and humidity of the
expired gases between patients with cystic fibrosis and
healthy individuals breathing ambient air.
Limitations
Possible limitations of this study must be clarified. First,
although the level of humidity during ventilator CPAP was
higher than the required minimum, we have no data on longer
term use. Global patient comfort, without distinguishing noise,
claustrophobia or sensation of heat, was also evaluated only
over a short period. Second, only one type of helmet was used,
with an internal volume of 15 l. However, similar to the case of
'carbon dioxide rebreathing' [25], the volume of the helmet
should not directly influence the final level of humidity of the
medical gases but only the rate at which the level is reached.
We did not also measure leakages from the helmet during the
intermittent gas flow delivered by the ventilator. By increasing
the gas flow through the helmet, these leakages could result
in greater dilution of heat and humidity of expired gases, reduc-
ing the temperature and humidity of the inspired gases. Third,
because the overall duration of the study was no longer than 2
hours, this prevented us from evaluating other ventilatory
modes. However, the data we obtained during ventilator
CPAP (intermittent flow) could be also obtained during vol-
ume-controlled or pressure-controlled modes.
Conclusion
During ventilator CPAP without a heated humidifier, the use of
a helmet – acting as a mixing chamber between expired and
inspired medical gases – increased the humidity of the
inspired dry gases to a degree similar to that of ambient air.
However, the level of humidity reached with continuous flow
CPAP systems, was lower than that of ambient air, and in
these cases a heated humidifier is probably indicated.
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